HCA Healthcare, Inc.
HCA
$429.24
$0.050.01%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 78.01B | 76.39B | 75.60B | 74.37B | 72.70B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 78.01B | 76.39B | 75.60B | 74.37B | 72.70B |
| Cost of Revenue | 44.80B | 44.60B | 44.23B | 43.60B | 42.97B |
| Gross Profit | 33.22B | 31.79B | 31.37B | 30.77B | 29.73B |
| SG&A Expenses | 1.03B | 1.03B | 1.03B | 1.05B | 1.05B |
| Depreciation & Amortization | 3.67B | 3.59B | 3.52B | 3.47B | 3.42B |
| Other Operating Expenses | 16.44B | 15.19B | 14.86B | 14.62B | 14.18B |
| Total Operating Expenses | 65.94B | 64.42B | 63.64B | 62.74B | 61.62B |
| Operating Income | 12.07B | 11.97B | 11.97B | 11.63B | 11.08B |
| Income Before Tax | 9.87B | 9.79B | 9.83B | 9.29B | 8.78B |
| Income Tax Expenses | 2.02B | 1.98B | 2.05B | 1.99B | 1.90B |
| Earnings from Continuing Operations | 7.85K | 7.81K | 7.78K | 7.31K | 6.88K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.01B | -1.02B | -998.00M | -961.00M | -913.00M |
| Net Income | 6.84B | 6.79B | 6.78B | 6.34B | 5.97B |
| EBIT | 12.07B | 11.97B | 11.97B | 11.63B | 11.08B |
| EBITDA | 15.75B | 15.57B | 15.49B | 15.10B | 14.50B |
| EPS Basic | 30.14 | 29.35 | 28.63 | 26.12 | 24.01 |
| Normalized Basic EPS | 22.60 | 21.93 | 21.61 | 20.45 | 18.89 |
| EPS Diluted | 29.87 | 29.08 | 28.38 | 25.87 | 23.79 |
| Normalized Diluted EPS | 22.39 | 21.72 | 21.42 | 20.26 | 18.73 |
| Average Basic Shares Outstanding | 907.73M | 926.36M | 949.71M | 974.31M | 998.18M |
| Average Diluted Shares Outstanding | 916.37M | 935.45M | 958.24M | 982.84M | 1.01B |
| Dividend Per Share | 3.00 | 2.94 | 2.88 | 2.82 | 2.76 |
| Payout Ratio | 9.97% | 10.04% | 10.01% | 10.75% | 11.47% |